Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q4 Earnings
COLLCollegium Pharmaceutical(COLL) Zacks Investment Research·2024-02-23 09:01

For the quarter ended December 2023, Collegium Pharmaceutical (COLL) reported revenue of 149.75million,up15.5149.75 million, up 15.5% over the same period last year. EPS came in at 1.58, compared to 1.09intheyear−agoquarter.ThereportedrevenuecomparestotheZacksConsensusEstimateof1.09 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of 147.66 million, representing a surprise of +1.41%. The company delivered an EPS surprise of +18.80%, with the consensus EPS estimate being $1.33. While investors closely watch year-over-year changes in headline numbers -- revenue and ...